Green Oaks, IL, United States of America

Alexander R Shoemaker

USPTO Granted Patents = 8 

Average Co-Inventor Count = 8.8

ph-index = 4

Forward Citations = 182(Granted Patents)


Company Filing History:


Years Active: 2010-2015

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Work of Inventor Alexander R. Shoemaker

Introduction:

Alexander R. Shoemaker, a talented inventor based in Green Oaks, IL, US, has made significant contributions to the field of pharmaceuticals and biotechnology. With a total of 8 patents to his name, Shoemaker has demonstrated a keen understanding of innovation and scientific discovery.

Latest Patents:

One of Shoemaker's recent patents involves the development of Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases. These compounds, along with their pharmaceutical salts, have shown promising results in inhibiting kinases like wee-1. The compositions containing these compounds have the potential to revolutionize the treatment of diseases such as cancer.

Career Highlights:

During his career, Shoemaker has been associated with renowned companies in the pharmaceutical industry. He has worked at Abbott Laboratories Corporation and AbbVie Inc., where his innovative ideas and groundbreaking research have been instrumental in driving scientific advancements.

Collaborations:

In his pursuit of innovation, Shoemaker has collaborated with esteemed professionals in the field. Some of his coworkers, such as Milan Bruncko and Hong Ding, have contributed their expertise to joint projects, further solidifying Shoemaker's reputation as a collaborative and forward-thinking inventor.

Conclusion:

Alexander R. Shoemaker's work exemplifies the spirit of innovation and creativity in the pharmaceutical and biotechnology sectors. His patents and collaborations underscore his commitment to pushing the boundaries of scientific discovery, ultimately contributing to the development of novel treatments for challenging diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…